Dr. Emily Watson

Dr. Emily Watson oversees clinical trial coverage and regulatory news at BioAge Insider. As a board-certified internist with fellowship training in gerontology, she brings clinical expertise to her analysis of longevity interventions and their path to approval. Emily practiced geriatric medicine for eight years at Johns Hopkins before transitioning to medical journalism. She has served on FDA advisory committees and continues to consult for longevity biotech companies on clinical trial design. Her coverage focuses on translating complex clinical data into actionable insights for readers interested in the latest therapeutic developments. Emily is a member of the American Geriatrics Society and the Gerontological Society of America.